Balance Sheet Quanterix Corporation

Equities

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-12 pm EDT			5-day change	1st Jan Change
4.760 ^USD	-4.99%		-18.77%	-25.16%

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

c47da2ecd14baa5853f89dce7.uMybydMCmpkAwQHEuPQMgjohs0uQGJu_ZNUrgj2SzQo.-_j9nYpX1K5Kt2KUjM1o5AhH5AbDIOrbUOIbxgrIpDyN-azxikj-zUv3UA

Published financial data: QUANTERIX CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	111M	106M	122M	137M	139M
Total Revenues	111M	106M	122M	137M	139M
Cost of Goods Sold, Total	48.55M	58.72M	51.72M	54.32M	73.94M
Gross Profit	62M	46.81M	70.65M	83.1M	64.96M
Selling General & Admin Expenses, Total	92.34M	92M	90.24M	102M	121M
R&D Expenses	27.98M	25.89M	24.86M	31.08M	30.82M
Other Operating Expenses, Total	120M	118M	115M	133M	152M
Operating Income	-58.31M	-71.08M	-44.45M	-49.6M	-86.57M
Interest Expense, Total	-403K	-	-	-	-
Interest And Investment Income	-	5.13M	15.84M	14.66M	8.57M
Net Interest Expenses	-403K	5.13M	15.84M	14.66M	8.57M
Currency Exchange Gains (Loss)	-835K	-	-	-600K	-
Other Non Operating Income (Expenses)	-	-62K	-	-	157K
EBT, Excl. Unusual Items	-59.55M	-66.01M	-28.61M	-35.54M	-77.85M
Restructuring Charges	-	-30.62M	-3.71M	-3.02M	-8.84M
Merger & Related Restructuring Charges	-275K	-	-	-	-12.4M
Impairment of Goodwill	-	-	-	-	-6.37M
Asset Writedown	-	-	-1.54M	-	-1.35M
Other Unusual Items	2.1M	-	2.25M	464K	-5.45M
EBT, Incl. Unusual Items	-57.72M	-96.64M	-31.62M	-38.1M	-112M
Income Tax Expense	-36K	65K	719K	434K	-5.12M
Earnings From Continuing Operations	-57.69M	-96.7M	-32.33M	-38.53M	-107M
Net Income to Company	-57.69M	-96.7M	-32.33M	-38.53M	-107M
Net Income - (IS)	-57.69M	-96.7M	-32.33M	-38.53M	-107M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-57.69M	-96.7M	-32.33M	-38.53M	-107M
Net Income to Common Excl. Extra Items	-57.69M	-96.7M	-32.33M	-38.53M	-107M
Per Share Items
Net EPS - Basic	-1.6	-2.61	-0.86	-1	-2.51
Basic EPS - Continuing Operations	-1.6	-2.61	-0.86	-1	-2.51
Basic Weighted Average Shares Outstanding	36M	36.99M	37.59M	38.37M	42.64M
Net EPS - Diluted	-1.6	-2.61	-0.86	-1	-2.51
Diluted EPS - Continuing Operations	-1.6	-2.61	-0.86	-1	-2.51
Diluted Weighted Average Shares Outstanding	36M	36.99M	37.59M	38.37M	42.64M
Normalized Basic EPS	-1.03	-1.12	-0.48	-0.58	-1.14
Normalized Diluted EPS	-1.03	-1.12	-0.48	-0.58	-1.14
Supplemental Items
EBITDA	-53.46M	-65.73M	-38.09M	-43.13M	-71.93M
EBITA	-56.31M	-69.28M	-42.85M	-48M	-78.97M
EBIT	-58.31M	-71.08M	-44.45M	-49.6M	-86.57M
EBITDAR	-48.06M	-56.83M	-28.88M	-33.82M	-60.26M
Total Revenues (As Reported)	111M	106M	122M	137M	139M
Effective Tax Rate - (Ratio)	0.06	-0.07	-2.27	-1.14	4.56
Current Domestic Taxes	30K	77K	161K	37K	93K
Current Foreign Taxes	342K	368K	850K	683K	416K
Total Current Taxes	372K	445K	1.01M	720K	509K
Deferred Domestic Taxes	1K	-23K	-	-	-5.25M
Deferred Foreign Taxes	-409K	-357K	-292K	-286K	-381K
Total Deferred Taxes	-408K	-380K	-292K	-286K	-5.63M
Normalized Net Income	-37.22M	-41.26M	-17.88M	-22.21M	-48.65M
Supplemental Operating Expense Items
Advertising Expense	-	-	300K	500K	-
Selling and Marketing Expenses	-	-	300K	500K	-
Research And Development Expense From Footnotes	27.98M	25.89M	24.86M	31.08M	37.12M
Net Rental Expense, Total	5.4M	8.9M	9.2M	9.31M	11.66M
Imputed Operating Lease Interest Expense	661K	-	-	-	-
Imputed Operating Lease Depreciation	4.74M	-	-	-	-
Stock-Based Comp., COGS (Total)	874K	1.43M	1.95M	2.27M	1.87M
Stock-Based Comp., R&D Exp. (Total)	1.81M	1.64M	1.7M	2.12M	2.18M
Stock-Based Comp., SG&A Exp. (Total)	13.29M	12.38M	13.11M	15.6M	16.67M
Total Stock-Based Compensation	15.98M	15.44M	16.76M	19.99M	20.72M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	396M	339M	174M	56.71M	29.84M
Short Term Investments	-	-	147M	232M	88.39M
Total Cash And Short Term Investments	396M	339M	321M	289M	118M
Accounts Receivable, Total	23.79M	19.02M	25.41M	32.14M	29.97M
Total Receivables	23.79M	19.02M	25.41M	32.14M	29.97M
Inventory	22.19M	16.79M	22.36M	32.78M	54.76M
Prepaid Expenses	6.07M	6.48M	9M	9.56M	9.29M
Other Current Assets, Total	440K	377K	288K	-	-
Total Current Assets	449M	381M	378M	364M	212M
Gross Property Plant And Equipment	37.16M	52.35M	50.3M	52.31M	66.16M
Accumulated Depreciation	-7.7M	-10.96M	-14.12M	-18.82M	-25.83M
Net Property Plant And Equipment	29.45M	41.38M	36.18M	33.49M	40.34M
Long-term Investments	-	-	-	800K	-
Goodwill	9.63M	-	-	-	26.38M
Other Intangibles, Total	10.53M	7.52M	6.03M	4.03M	132M
Deferred Tax Assets Long-Term	-	-	-	-	31.93M
Other Long-Term Assets, Total	2.96M	3.9M	4.41M	4.62M	-23.92M
Total Assets	502M	434M	425M	407M	419M
Liabilities
Accounts Payable, Total	9.21M	3.84M	5.05M	6.95M	13.57M
Accrued Expenses, Total	19.08M	15.23M	18.89M	20.45M	23.56M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	1.43M	2.69M	4.24M	4.76M	7.92M
Current Income Taxes Payable	430K	172K	808K	1.02M	1.12M
Unearned Revenue Current, Total	6.36M	8.64M	9.47M	8.83M	20.73M
Other Current Liabilities	470K	386K	-	-	7.87M
Total Current Liabilities	36.98M	30.96M	38.46M	42.01M	74.76M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	20.46M	41.42M	37.22M	32.62M	29.32M
Unearned Revenue Non Current	1.1M	1.42M	1.23M	1.07M	5.83M
Deferred Tax Liability Non Current	2.04M	1.47M	1.18M	800K	-32.38M
Other Non Current Liabilities	-	-	-	-	45.5M
Total Liabilities	60.58M	75.26M	78.08M	76.5M	123M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	37K	37K	38K	39K	47K
Additional Paid In Capital	746M	764M	783M	803M	874M
Retained Earnings	-305M	-402M	-434M	-470M	-577M
Comprehensive Income and Other	441K	-2.62M	-1.76M	-3.08M	-723K
Total Common Equity	441M	359M	347M	330M	296M
Total Equity	441M	359M	347M	330M	296M
Total Liabilities And Equity	502M	434M	425M	407M	419M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	36.85M	37.25M	38.06M	38.78M	46.94M
ECS Total Common Shares Outstanding	36.77M	37.28M	38.01M	38.54M	46.74M
Book Value / Share	11.99	9.63	9.13	8.56	6.33
Tangible Book Value	421M	351M	341M	326M	138M
Tangible Book Value Per Share	11.44	9.43	8.97	8.46	2.94
Total Debt	21.89M	44.1M	41.46M	37.37M	37.24M
Net Debt	-375M	-295M	-280M	-252M	-80.99M
Debt Equivalent Oper. Leases	43.2M	71.2M	73.64M	74.46M	93.3M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	7.89M	5.51M	5.11M	7.22M	13.73M
Inventories - Work In Process, Total	4.92M	3.36M	4.47M	7.98M	11.03M
Inventories - Finished Goods, Total	9.38M	7.92M	12.78M	17.58M	30.01M
Machinery, Total	15.25M	17.44M	18.97M	22.68M	30.72M
Full Time Employees	460	370	441	471	450
Accumulated Allowance for Doubtful Accounts (Supple)	419K	118K	454K	1.04M	2.37M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-57.69M	-96.7M	-32.33M	-38.53M	-107M
Depreciation & Amortization - CF	2.85M	3.55M	6.78M	6.76M	10.12M
Amortization of Goodwill and Intangible Assets - (CF)	2M	1.8M	1.6M	1.6M	7.6M
Depreciation & Amortization, Total	4.85M	5.35M	8.38M	8.36M	17.72M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	1.2M
(Gain) Loss From Sale Of Asset	89K	6K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-1.96M	-6.83M	-2.08M
Asset Writedown & Restructuring Costs	-	25.59M	1.57M	-	7.75M
Stock-Based Compensation (CF)	15.98M	15.44M	16.76M	19.99M	20.72M
Provision and Write-off of Bad Debts	213K	-301K	336K	588K	628K
Other Operating Activities, Total	839K	270K	150K	55K	-13.68M
Change In Accounts Receivable	-6.85M	5.16M	-6.7M	-7.7M	10.61M
Change In Inventories	-8.09M	5.39M	-5.36M	-6.68M	4.03M
Change In Accounts Payable	2.41M	-5.36M	1.19M	723K	-528K
Change in Unearned Revenues	1.46M	2.6M	635K	-794K	-
Change in Other Net Operating Assets	-1.12M	-5.71M	-1.57M	-4.33M	-16.46M
Cash from Operations	-47.91M	-48.27M	-18.9M	-35.16M	-77.24M
Capital Expenditure	-13.62M	-11.73M	-3.79M	-3.37M	-2.61M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-93.23M
Investment in Marketable and Equity Securities, Total	-	-	-145M	-78.9M	146M
Other Investing Activities, Total	7.28M	520K	-	-	-
Cash from Investing	-6.34M	-11.21M	-148M	-82.26M	50.23M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-7.74M	-	-	-	-
Total Debt Repaid	-7.74M	-	-	-	-
Issuance of Common Stock	279M	2.31M	2.89M	3.07M	738K
Repurchase of Common Stock	-	-	-198K	-2.61M	-1.45M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	271M	2.31M	2.69M	456K	-708K
Foreign Exchange Rate Adjustments	-92K	-538K	301K	-734K	1.57M
Net Change in Cash	216M	-57.7M	-164M	-118M	-26.14M
Supplemental Items
Cash Interest Paid	389K	-	-	-	-
Cash Income Tax Paid (Refund)	-	684K	808K	875K	-1.4M
Levered Free Cash Flow	-39.3M	-32.81M	-14.89M	-17.21M	-7.03M
Unlevered Free Cash Flow	-39.05M	-32.81M	-14.89M	-17.21M	-7.03M
Change In Net Working Capital	9.82M	-2.55M	8.46M	11.19M	-10.04M
Net Debt Issued / Repaid	-7.74M	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-9.43	-9.5	-6.47	-7.42	-13.11
Return on Total Capital	-10.42	-10.26	-7.02	-8.17	-15.45
Return On Equity %	-17.83	-24.18	-9.16	-11.33	-34.25
Return on Common Equity	-17.83	-24.18	-9.16	-11.33	-34.25
Margin Analysis
Gross Profit Margin %	56.08	44.36	57.73	60.47	46.77
SG&A Margin	83.52	87.18	73.75	73.95	86.9
EBITDA Margin %	-48.36	-62.29	-31.13	-31.39	-51.78
EBITA Margin %	-50.93	-65.65	-35.02	-34.93	-56.86
EBIT Margin %	-52.74	-67.36	-36.33	-36.09	-62.33
Income From Continuing Operations Margin %	-52.18	-91.64	-26.42	-28.04	-77.14
Net Income Margin %	-52.18	-91.64	-26.42	-28.04	-77.14
Net Avail. For Common Margin %	-52.18	-91.64	-26.42	-28.04	-77.14
Normalized Net Income Margin	-33.66	-39.1	-14.61	-16.16	-35.03
Levered Free Cash Flow Margin	-35.55	-31.09	-12.17	-12.53	-5.06
Unlevered Free Cash Flow Margin	-35.32	-31.09	-12.17	-12.53	-5.06
Asset Turnover
Asset Turnover	0.29	0.23	0.28	0.33	0.34
Fixed Assets Turnover	3.99	2.98	3.16	3.95	3.76
Receivables Turnover (Average Receivables)	5.4	4.93	5.51	4.78	4.47
Inventory Turnover (Average Inventory)	2.62	3.01	2.64	1.84	1.69
Short Term Liquidity
Current Ratio	12.14	12.32	9.84	8.66	2.84
Quick Ratio	11.37	11.56	9.02	7.65	1.98
Operating Cash Flow to Current Liabilities	-1.3	-1.56	-0.49	-0.84	-1.03
Days Sales Outstanding (Average Receivables)	67.63	74.03	66.26	76.64	81.61
Days Outstanding Inventory (Average Inventory)	139.25	121.14	138.14	198.43	216.07
Average Days Payable Outstanding	52.27	44.66	28.29	36.02	39.04
Cash Conversion Cycle (Average Days)	154.6	150.52	176.11	239.06	258.64
Long Term Solvency
Total Debt/Equity	4.96	12.29	11.95	11.32	12.59
Total Debt / Total Capital	4.73	10.94	10.68	10.17	11.18
LT Debt/Equity	4.64	11.54	10.73	9.88	9.92
Long-Term Debt / Total Capital	4.42	10.28	9.58	8.88	8.81
Total Liabilities / Total Assets	12.08	17.33	18.37	18.82	29.38
EBIT / Interest Expense	-144.69	-	-	-	-
EBITDA / Interest Expense	-119.26	-	-	-	-
(EBITDA - Capex) / Interest Expense	-153.04	-	-	-	-
Total Debt / EBITDA	-0.46	-0.78	-1.44	-1.1	-0.62
Net Debt / EBITDA	7.79	5.18	9.69	7.44	1.34
Total Debt / (EBITDA - Capex)	-0.35	-0.64	-1.27	-1	-0.59
Net Debt / (EBITDA - Capex)	6.07	4.3	8.57	6.77	1.29
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.99	-4.55	15.96	12.3	1.07
Gross Profit, 1 Yr. Growth %	26.79	-24.51	50.93	11.96	-21.83
EBITDA, 1 Yr. Growth %	101.36	22.95	-42.05	24.39	71.12
EBITA, 1 Yr. Growth %	95.78	23.03	-38.15	21.97	68.4
EBIT, 1 Yr. Growth %	88.94	21.9	-37.46	21.11	78.51
Earnings From Cont. Operations, 1 Yr. Growth %	82.96	67.63	-66.56	35.89	178.09
Net Income, 1 Yr. Growth %	82.96	67.63	-66.56	35.89	178.09
Normalized Net Income, 1 Yr. Growth %	90.96	10.66	-56.08	40.41	129.12
Diluted EPS Before Extra, 1 Yr. Growth %	49.77	63.12	-67.1	33.15	150.23
Accounts Receivable, 1 Yr. Growth %	38.42	-20.05	33.64	26.47	-6.75
Inventory, 1 Yr. Growth %	49.37	-24.35	33.24	25.46	67.09
Net Property, Plant and Equip., 1 Yr. Growth %	13.68	40.52	-12.58	-7.43	20.45
Total Assets, 1 Yr. Growth %	85.03	-13.42	-2.12	-5.14	3.01
Tangible Book Value, 1 Yr. Growth %	131.27	-16.48	-3	-5.21	-57.8
Common Equity, 1 Yr. Growth %	113.92	-18.6	-3.35	-5.69	-10.4
Cash From Operations, 1 Yr. Growth %	105.04	0.76	-60.84	86.56	119.64
Capital Expenditures, 1 Yr. Growth %	246.46	-13.88	-67.7	-12.31	-22.45
Levered Free Cash Flow, 1 Yr. Growth %	218.1	-16.52	-53.61	6.06	-57.44
Unlevered Free Cash Flow, 1 Yr. Growth %	220.49	-15.98	-53.61	6.06	-57.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	39.59	10.53	5.21	14.12	6.54
Gross Profit, 2 Yr. CAGR %	50.3	-2.17	6.98	35.35	-6.45
EBITDA, 2 Yr. CAGR %	21.73	57.34	-15.81	-20.29	44.02
EBITA, 2 Yr. CAGR %	22.23	55.2	-12.98	-18.07	41.66
EBIT, 2 Yr. CAGR %	22.14	51.76	-12.89	-17.74	45.4
Earnings From Cont. Operations, 2 Yr. CAGR %	18.91	75.13	-25.13	-37.79	94.4
Net Income, 2 Yr. CAGR %	18.91	75.13	-25.13	-37.79	94.4
Normalized Net Income, 2 Yr. CAGR %	24.41	45.49	-30.12	-28.32	85.62
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.85	56.63	-26.74	-38.92	82.53
Accounts Receivable, 2 Yr. CAGR %	47.68	5.2	3.37	30	8.6
Inventory, 2 Yr. CAGR %	45.63	6.3	0.39	39	44.79
Net Property, Plant and Equip., 2 Yr. CAGR %	56.35	26.39	10.83	-9.66	5.59
Total Assets, 2 Yr. CAGR %	71.78	26.57	-7.94	-3.17	-1.15
Tangible Book Value, 2 Yr. CAGR %	100.19	38.98	-9.99	-3.55	-36.76
Common Equity, 2 Yr. CAGR %	85.13	31.96	-11.3	-3.98	-8.07
Cash From Operations, 2 Yr. CAGR %	35.26	43.74	-37.19	-14.95	102.43
Capital Expenditures, 2 Yr. CAGR %	12.04	72.73	-47.26	-46.15	-17.54
Levered Free Cash Flow, 2 Yr. CAGR %	9.65	62.96	-38.19	-27.88	-34.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.3	64.1	-37.99	-27.88	-34.17
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	43.22	22.98	12.31	7.52	9.59
Gross Profit, 3 Yr. CAGR %	51.17	19.47	13.04	8.66	12.71
EBITDA, 3 Yr. CAGR %	21.11	22.13	12.78	-5.82	1.95
EBITA, 3 Yr. CAGR %	22.21	22.5	14.21	-4.16	3.37
EBIT, 3 Yr. CAGR %	22.85	22.06	12.93	-4.26	5.7
Earnings From Cont. Operations, 3 Yr. CAGR %	22.3	33.33	0.84	-11.48	2.47
Net Income, 3 Yr. CAGR %	22.3	33.33	0.84	-11.48	2.47
Normalized Net Income, 3 Yr. CAGR %	23.76	19.72	-2.83	-14.73	4.02
Diluted EPS Before Extra, 3 Yr. CAGR %	3.78	17.05	-6.89	-13.34	-2.27
Accounts Receivable, 3 Yr. CAGR %	51.86	20.36	13.93	10.56	16.37
Inventory, 3 Yr. CAGR %	55.12	17.07	14.61	13.88	47.79
Net Property, Plant and Equip., 3 Yr. CAGR %	115.99	50.89	11.77	4.38	-0.57
Total Assets, 3 Yr. CAGR %	95.03	36.71	16.18	-6.76	-1.15
Tangible Book Value, 3 Yr. CAGR %	124.06	49.58	23.28	-8.16	-26.78
Common Equity, 3 Yr. CAGR %	120.62	40.78	18.95	-9.21	-6.16
Cash From Operations, 3 Yr. CAGR %	18.6	22.61	-6.82	-9.61	16.69
Capital Expenditures, 3 Yr. CAGR %	107.77	2.63	-1.22	-37.32	-39.19
Levered Free Cash Flow, 3 Yr. CAGR %	32.26	0.13	6.42	-23.01	-40.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.98	0.13	6.91	-22.83	-40.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	44.44	35.77	26.6	19.36	9.97
Gross Profit, 5 Yr. CAGR %	51.58	36.2	31.53	24.8	5.84
EBITDA, 5 Yr. CAGR %	20.24	20.83	4.82	3.64	22.06
EBITA, 5 Yr. CAGR %	21	21.65	6.79	4.95	22.39
EBIT, 5 Yr. CAGR %	21.85	22.27	7.17	4.88	22.91
Earnings From Cont. Operations, 5 Yr. CAGR %	20.01	29.05	0.5	-1.14	27.72
Net Income, 5 Yr. CAGR %	20.01	29.05	0.5	-1.14	27.72
Normalized Net Income, 5 Yr. CAGR %	20.78	19.56	-1.85	-1.57	20.08
Diluted EPS Before Extra, 5 Yr. CAGR %	-34.09	-20.63	-9.72	-9.23	18.72
Accounts Receivable, 5 Yr. CAGR %	43.44	27.7	30.2	24.13	11.77
Inventory, 5 Yr. CAGR %	70.77	36.28	30.34	25.65	29.81
Net Property, Plant and Equip., 5 Yr. CAGR %	88.94	85.7	65.39	22.69	9.26
Total Assets, 5 Yr. CAGR %	68.32	36.45	44.44	19.06	9.09
Tangible Book Value, 5 Yr. CAGR %	29.6	39.78	55.57	25.43	-5.44
Common Equity, 5 Yr. CAGR %	30.81	40.37	53.23	20.73	7.49
Cash From Operations, 5 Yr. CAGR %	21.98	16.91	-8.03	6.07	27.01
Capital Expenditures, 5 Yr. CAGR %	91.7	59.61	20.07	-20.86	-7.85
Levered Free Cash Flow, 5 Yr. CAGR %	28.17	17.41	-2.6	-12.04	-10.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	29.91	18.38	-2.6	-12.04	-10.41